Candriam Equities L Biotech.R GBP Acc/ LU1269736911 /
| NAV2024-07-25 | Chg.+5.2200 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 391.8100GBP | +1.35% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | - | - | - | 1.78 | 6.34 | -0.22 | 13.38 | -0.98 | 4.89 | -7.09 | 6.69 | -1.70 | - |
| 2017 | 3.68 | 8.06 | -0.33 | -2.25 | -2.67 | 8.77 | 0.96 | 9.35 | -3.03 | -5.59 | -1.71 | 1.60 | +16.63% |
| 2018 | 1.56 | -1.50 | -3.82 | -1.36 | 8.33 | 1.66 | 5.15 | 5.15 | -2.36 | -12.19 | 4.34 | -8.09 | -5.01% |
| 2019 | 9.60 | 2.48 | 1.57 | -4.94 | -1.13 | 8.43 | 1.71 | -1.78 | -5.58 | 5.95 | 12.07 | 0.42 | +30.77% |
| 2020 | -4.75 | 1.68 | -2.07 | 10.52 | 11.77 | 1.40 | -8.64 | -1.09 | 4.37 | -2.62 | 6.07 | 0.63 | +16.46% |
| 2021 | 1.40 | -4.28 | -2.95 | 2.41 | -4.51 | 9.22 | -2.04 | 5.02 | -2.21 | -1.43 | -0.87 | 0.09 | -1.00% |
| 2022 | -9.68 | -1.51 | 8.13 | -2.66 | -4.29 | 7.47 | 4.56 | 6.25 | 2.32 | 3.31 | 2.71 | -3.77 | +11.79% |
| 2023 | 0.61 | -4.02 | -1.78 | 0.66 | 0.53 | -1.06 | -1.70 | 1.37 | -0.78 | -5.51 | 1.82 | 12.92 | +2.00% |
| 2024 | 1.66 | 2.09 | 0.16 | -5.36 | 2.17 | 6.47 | 5.00 | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 16.33% | 16.22% | 16.52% | 20.65% | 23.31% |
| Sharpe ratio | 1.19 | 1.06 | 1.15 | 0.25 | 0.31 |
| Best month | +12.92% | +6.47% | +12.92% | +12.92% | +12.92% |
| Worst month | -5.36% | -5.36% | -5.51% | -9.68% | -9.68% |
| Maximum loss | -9.15% | -9.15% | -9.16% | -20.06% | -22.16% |
| Outperformance | -2.38% | - | +0.14% | - | - |
All quotes in GBP
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotechnolog... | reinvestment | 2,286.9800 | +22.63% | +17.56% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 243.7100 | +23.94% | +27.10% | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,281.9399 | +20.02% | +9.12% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,456.6499 | +24.63% | +27.49% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,725.7200 | +22.30% | +24.47% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 391.8100 | +22.77% | +28.77% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 360.1900 | +25.10% | +30.50% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 221.7800 | +17.46% | +7.23% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 2,051.3999 | +23.27% | +20.87% | |
| Candriam Equities L Biotechnolog... | reinvestment | 165.2000 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 665.2100 | +21.44% | +15.58% | |
| Candriam Equities L Biotech.I US... | reinvestment | 6,255.2002 | +22.48% | +17.13% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 218.3800 | +19.44% | +8.94% | |
| Candriam Equities L Biotech.R US... | reinvestment | 297.2000 | +22.96% | +19.96% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 228.0600 | +20.44% | +11.65% | |
| Candriam Equities L Biotechnolo... | reinvestment | 934.3600 | +21.88% | +17.02% | |
| Candriam Equities L Biotechnolog... | paying dividend | 853.2800 | +21.84% | +16.91% |
Performance
| YTD | +12.38% | ||
|---|---|---|---|
| 6 Months | +9.95% | ||
| 1 Year | +22.77% | ||
| 3 Years | +28.77% | ||
| 5 Years | +68.25% | ||
| 10 Years | - | ||
| Since start | +161.21% | ||
| Year | |||
| 2023 | +2.00% | ||
| 2022 | +11.79% | ||
| 2021 | -1.00% | ||
| 2020 | +16.46% | ||
| 2019 | +30.77% | ||
| 2018 | -5.01% | ||
| 2017 | +16.63% | ||
